BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32668853)

  • 21. High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance.
    Chen AR; Wang YM; Lin M; Kuo DJ
    Cureus; 2020 Jun; 12(6):e8674. PubMed ID: 32699674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury.
    Sakran R; Milo G; Jabareen A; Artul T; Haim N; Litvak M; Ringelstein-Harlev S; Horowitz N; Efrati E; Assady S; Kurnik D
    J Oncol Pharm Pract; 2022 Mar; 28(2):508-515. PubMed ID: 34668443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
    Winter SS; Dunsmore KP; Devidas M; Wood BL; Esiashvili N; Chen Z; Eisenberg N; Briegel N; Hayashi RJ; Gastier-Foster JM; Carroll AJ; Heerema NA; Asselin BL; Gaynon PS; Borowitz MJ; Loh ML; Rabin KR; Raetz EA; Zweidler-Mckay PA; Winick NJ; Carroll WL; Hunger SP
    J Clin Oncol; 2018 Oct; 36(29):2926-2934. PubMed ID: 30138085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein.
    Ikemura K; Hiramatsu SI; Shinogi Y; Nakatani Y; Tawara I; Iwamoto T; Katayama N; Okuda M
    Sci Rep; 2019 Dec; 9(1):20359. PubMed ID: 31889141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and managing methotrexate nephrotoxicity.
    Widemann BC; Adamson PC
    Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination.
    Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA
    J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concepts in use of high-dose methotrexate therapy.
    Treon SP; Chabner BA
    Clin Chem; 1996 Aug; 42(8 Pt 2):1322-9. PubMed ID: 8697606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucarpidase for the treatment of life-threatening methotrexate overdose.
    Tuffaha HW; Al Omar S
    Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
    Ibarra M; Combs R; Taylor ZL; Ramsey LB; Mikkelsen T; Buddington RK; Heldrup J; Barreto JN; Guscott M; Lowe J; Hurmiz C; Marada S; Howard SC; Schaiquevich P
    Br J Clin Pharmacol; 2023 Feb; 89(2):660-671. PubMed ID: 35998099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
    Wang Y; Wei L; Guan Y; Wang Q; Xie Q; Hao C
    Ren Fail; 2020 Nov; 42(1):1111-1117. PubMed ID: 33164656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of interleukin-11 on high-dose methotrexate (HDMTX) induced mucositis in Wistar rats].
    Han YQ; Chen LJ; Sun XJ; Zhao GF; Cheng XY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):740-4. PubMed ID: 15730719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe renal impairment of methotrexate elimination after high dose therapy].
    Lawrenz-Wolf B; Wolfrom C; Frickel C; Fengler R; Wehinger H; Henze G
    Klin Padiatr; 1994; 206(4):319-26. PubMed ID: 7967432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy.
    Inose R; Takahashi K; Nanno S; Hino M; Nagayama K
    J Chemother; 2019 Feb; 31(1):30-34. PubMed ID: 30773130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia.
    Li H; Xu Q; Wang Y; Chen K; Li J
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):95-103. PubMed ID: 31676986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.
    Fox E; Busch C; DeBernardo A; Segers B; Gottschalk J; Womer R; Balamuth N; Bagatell R; Balis F
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):807-815. PubMed ID: 33677616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Dose Methotrexate: Nursing Considerations for Administration and Supportive Care.
    Roche B; Clarke PA; Ford D; Collins Shaver S; Thompson J
    Clin J Oncol Nurs; 2023 Jan; 27(1):47-54. PubMed ID: 37677820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.
    Wang X; Song Y; Wang J; He J; Liu R; Li X; Huang H; Zhang J
    Int J Clin Pharm; 2020 Feb; 42(1):23-30. PubMed ID: 31916121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate.
    Joerger M; Ferreri AJ; Krähenbühl S; Schellens JH; Cerny T; Zucca E; Huitema AD
    Br J Clin Pharmacol; 2012 Feb; 73(2):240-7. PubMed ID: 21838788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
    Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.